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Background: Most evidence on the effect of collaborative care for depression is derived in the selective
environment of randomised controlled trials. In collaborative care, practice nurses may act as case managers. The
Primary Care Services Improvement Project (PCSIP) aimed to assess the cost-effectiveness of alternative models of
practice nurse involvement in a real world Australian setting. Previous analyses have demonstrated the value of high
level practice nurse involvement in the management of diabetes and obesity. This paper reports on their value in
the management of depression.
Methods: General practices were assigned to a low or high model of care based on observed levels of practice
nurse involvement in clinical-based activities for the management of depression (i.e. percentage of depression
patients seen, percentage of consultation time spent on clinical-based activities). Linked, routinely collected data
was used to determine patient level depression outcomes (proportion of depression-free days) and health service
usage costs. Standardised depression assessment tools were not routinely used, therefore a classification framework
to determine the patient’s depressive state was developed using proxy measures (e.g. symptoms, medications,
referrals, hospitalisations and suicide attempts). Regression analyses of costs and depression outcomes were
conducted, using propensity weighting to control for potential confounders.
Results: Capacity to determine depressive state using the classification framework was dependent upon the level
of detail provided in medical records. While antidepressant medication prescriptions were a strong indicator of
depressive state, they could not be relied upon as the sole measure. Propensity score weighted analyses of total
depression-related costs and depression outcomes, found that the high level model of care cost more (95% CI:
-$314.76 to $584) and resulted in 5% less depression-free days (95% CI: -0.15 to 0.05), compared to the low level
model. However, this result was highly uncertain, as shown by the confidence intervals.
Conclusions: Classification of patients’ depressive state was feasible, but time consuming, using the classification
framework proposed. Further validation of the framework is required. Unlike the analyses of diabetes and obesity
management, no significant differences in the proportion of depression-free days or health service costs were found
between the alternative levels of practice nurse involvement.
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Globally, depression is the most common mental health
disorder with a point prevalence between four and ten per-
cent [1]. Depression has been identified as a health priority
area in many countries, including Australia. It is estimated
that 11.6% of Australians have experienced a depressive epi-
sode at some point in their life [2] and depression costs the
Australian economy AU$14.9 billion per year [3]. Depres-
sion is the second most frequently managed chronic prob-
lem in Australian general practice [4].
Multiple systematic reviews and meta-analyses have
found that collaborative care for depression is effective
[5-7], and cost-effective [8,9]. Collaborative care involves
a team based approach, where team members include
the primary care physician (GP), a case manager (often a
practice nurse) and a mental health specialist (e.g. psych-
iatrist, psychologist). The case manager’s role includes
the systematic identification, management and follow-up
of depressed patients. Adequate mental health training
for the case manager was found to be a key determinant
of effectiveness. The Australian Government offers fi-
nancial incentives for general practices to employ prac-
tice nurses and to expand and enhance their role within
the practice [10]. A practice nurse is a qualified nurse
employed by a general practice to provide nursing man-
agement under the supervision of a general practitioner.
The number of practice nurses in Australia increased
from 3,255 in 2003–04 to 10,085 in 2009–10, with 58%
of practices employing a practice nurse [11]. In 2009–10,
Government practice nurse incentives totalled AU$55.3
million [12]. To date, studies of the Australian practice
nurse workforce have been mainly descriptive, with little
focus on models of practice or determining impact on
health outcomes [13].
In Australia, the TrueBlue randomised control trial is
the main study of practice nurse management of depres-
sion [14-16]. It examined clinical outcomes (e.g. reduc-
tion in depression score) associated with practice nurse
led collaborative care for the management of moderate
to severe depression comorbid with type 2 diabetes or
coronary heart disease. The intervention comprised in-
tensive training, supporting materials, access to a local
facilitator, and monthly peer-support teleconferences.
While both the intervention and control groups demon-
strated a significant reduction in depression intensity
after six months, the reduction was significantly larger
in the intervention group.
As with the TrueBlue study, internationally, much of the
evidence on the effectiveness of nurse involvement in col-
laborative care has been gathered via RCTs [5-7]. However,
limitations exist, particularly when evaluating health care
interventions with complex treatment pathways that are
best represented as models of care. Questions remain about
the external validity of RCTs conducted under highlycontrolled conditions with carefully selected patient popula-
tions [17]. Compared to RCTs, observational studies can
offer greater external validity, and determine the effective-
ness of interventions as applied in a real world setting.
Risk adjusted cost-effectiveness (RAC-E) is a method
of analysis for identifying important differences in rou-
tinely provided services. RAC-E analysis has previously
been applied to hospital services [18]. The Primary Care
Services Improvement Project (PCSIP) was a retrospect-
ive observational study, which used RAC-E methods to
assign general practices to models of care based on ob-
served differences in practice nurse activity in the
provision of clinical-based services. Three case studies
were conducted [19,20], with this paper reporting on the
depression case study.
RAC-E analysis uses routinely collected data to iden-
tify patient characteristics, and to track health outcomes
and health care costs. Standardised assessment tools for
depression are not consistently used within general prac-
tice or recorded in routine data. While previous studies
have used proxy measures, such as antidepressant pre-
scriptions, there is no clearly defined methodology to de-
termine depressive state in the absence of standardised
assessment tools or diagnostic interview [21-23]. As an
illustrative case study of a RAC-E analysis, the PCSIP
aimed to evaluate whether, from the perspective of the
health-care system, a high level model of practice nurse
involvement in the management of depression in pri-
mary care was more cost-effective than a low level
model of practice nurse involvement. A secondary aim
was to develop and test the feasibility of a depression
state classification framework for use with routinely col-
lected, general practice data. This paper describes the
methodology developed to classify the depression status
of patients, and reports the within trial cost-effectiveness
findings of the RAC-E analysis.
Methods
Practice recruitment and classification of model of care
The recruitment of general practices and patients has
been described in detail elsewhere [24]. Practices were
recruited from within the Adelaide Northern Division
of General Practice (ANDGP), which is located in
the northern suburbs of metropolitan Adelaide, South
Australia. All 66 practices in the ANDGP were contacted.
Ten practices with practice nurses agreed to participate in
the PCSIP.
Practice nurses within the participating practices were
surveyed to determine their level of involvement in clinical-
based activities in the management of depression (e.g. pa-
tient education, self-management advice, monitoring of
treatment adherence). Level of involvement was deter-
mined based on two questions within the survey: (1) What
is your best estimate of the percentage of patients with
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in your practice? (2) In an average consultation with a DE-
PRESSED patient, what percentage of time do you spend
providing education and self-management advice, monitor-
ing clinical progress, and assessing and enhancing treat-
ment adherence? Where the average response of the
practice nurses within a practice was greater than 50% on
both these questions, the practice was considered to show a
high level of practice nurse involvement and assigned to
the high level model of care. If high level criteria were not
met, the practice was assigned to the low level model of
care.
To identify any further differences between the models of
care, the following were also analysed: responses to other
questions in the practice nurse survey regarding the prac-
tice environment and practice nurse characteristics (e.g.
age, gender, education and experience); billing of Medicare
service item number 10997, which covers ‘provision of
monitoring and support for a person with a chronic disease
by a practice nurse or Aboriginal and Torres Strait Islander
health practitioner’ [25]; and the billing of Medicare mental
health service item numbers (2702, 2710 and 2712), which
covered preparation and review of mental health care plans
by GPs.
Patient recruitment
Within participating practices, eligible patients were identi-
fied using the Pen Computer Systems Clinical Audit Tool
(CAT). The CAT tool identified patients who had a diagno-
sis of depression listed in their medical history summary.
This meant we were more likely to select patients who had
experienced depression severe enough to warrant a diagno-
sis and ongoing monitoring or intervention, rather than
patients with a milder, transient experience of ‘feeling de-
pressed’ (which would be recorded in the general consult-
ation notes). Eligible patients were aged between 18 and 75
years, regularly visited the practice (i.e. at least 3 times in
the last 2 years), were not under regular psychiatric care,
not pregnant, not living in a managed care facility and did
not have a severe mental disorder or mental impairment
(e.g. schizophrenia, bipolar disorder, or dementia). After re-
cruitment, but prior to data analysis, eligibility criteria were
further refined to exclude patients for whom less than 50%
of their GP visits during the study period were to the par-
ticipating practice (as indicated by Medicare billing of GP
visit item numbers). Patients were asked for consent to ac-
cess their medical records held by the participating general
practice, Medicare Australia (the federal government de-
partment which organises and distributes payment for Aus-
tralia’s publically funded, universal health care system) and
SA Health. There was no intervention within the study de-
sign. Sample size calculations estimated that 100 patients
per model of care were required, details of calculations have
been provided elsewhere [24].Ethics approval was granted by the Human Research
Ethics Committees of the University of Adelaide and SA
Health (the South Australian Department of Health).
Data sources and data collection
Data were collected for the period between October 2007
and October 2010 from three sources: patient medical re-
cords held at general practices, Medicare Australia, and SA
Health.
Patient medical records provided information on pa-
tient characteristics (e.g. age, gender, comorbidities), re-
ferrals to specialists and allied health professionals,
prescriptions written, GP management plans prepared or
reviewed, scores on any standardised assessment tools
for depression and general medical notes. Record infor-
mation was extracted from the practice and entered
directly into a purpose built Access 2007 database
(Microsoft Office 2007, Microsoft Corporation), with
identifying information removed.
Medicare Australia provided data on out-of-hospital
health service usage and costs, including GP visits,
management plan preparation or review, psychological
services provided under the Better Access Initiative, spe-
cialist visits, and prescriptions provided under the gov-
ernment subsidised Pharmaceutical Benefits Scheme
(PBS). Unit costs were allocated as per the year incurred.
SA Health provided information on public and private
inpatient hospital services, to which 2008–09 average
diagnosis related group (DRG) costs were applied. The
evaluation took the perspective of the health-care sys-
tem, thus only direct health-care costs were included.
Data from each source were cleaned, formatted and
linked to create comprehensive individual patient records.
Classification of depression state
To track the progression of depression, the depression
state of each patient needed to be categorised through-
out the study period. Standardised assessment tools for
depression, such as the DASS-21 or the Hamilton Rating
Scale for Depression, were not routinely used or re-
corded within the obtained data, therefore proxy mea-
sures had to be developed.
A proposed model structure (Figure 1) for cost-
effectiveness analyses of depression management includes
six clinically and economically relevant depression-related
states, based on the natural history of depression [23].
Howell [26] published a ‘Case note audit form’, which
was used to identify relapse in depression patients from
general practice medical records. The audit form con-
tained detailed lists of depression symptoms, treatment
options, depression-related medications and mental
health services to which a patient could be referred. In a
prior publication [23], we suggested a method of incorp-
orating changes to treatment and GP notes as proxy
Figure 1 Depression model showing depressive states and transitions. Ovals indicate states, arrows indicate transitions between states.
Patients may transition into the death state from any other state (i.e. all cause mortality). Adapted from [23].
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states beyond relapse. In practice the proposed method
required simplification in order to apply, resulting in the
following conceptualisation of the symptoms and timing
of depressive states:
 Depressive episode – significant symptom intensity
described, with impact on daily living.
 Chronic depression – low or moderate symptoms of
depression are recorded and appear to have been
present for two or more years.
 Hospital admission – where the reason for
admission is depression-related. Reason for admission
may be determined via general notes in the GP
records, discharge summaries provided to the GP, or
diagnosis related data provided by SA Health.
 Response – patient experiences a substantial
reduction in depressive symptoms (e.g. symptoms
appear to ‘halve’). Response period is considered to
last a minimum of eight weeks, but may last longer
if symptoms remain reduced but do not fully abate.
 Remission – patient is symptom free or experiences
very minimal symptoms. Remission is considered to
last for six months following response.
 Recovery – a patient who remains asymptomatic
and has spent six months in the remission state is
considered to transition into the recovery state.
In addition to the symptom intensity and timing de-
scribed above, antidepressant medications, psychology
and psychiatry referrals, emergency department referrals
or suicide attempts were also incorporated. Further de-
tails on the classification process are provided in the ap-
pendix (see Additional file 1).
While the analyses described in this paper ultimately
required the classification of only two states – depres-
sion or depression-free – it was intended that the data-
set would also be used to populate a decision analytic
model based on the proposed model structure. Hence, it
was important that the classification system be able to
identify all six depressive states shown in Figure 1, andthat the proposed model structure was congruent with
the observed data.
Analysis
All analyses were undertaken using STATA, Release 12
(StataCorp). The duration of a patient’s participation in
the study was calculated as the number of days between
the first and last visits at which the patient’s depressive
state could be determined.
The number of depression-free days were calculated as
the total number of days spent in either the remission or
recovery states. In all other states, including response,
the patient experienced some degree of depression. For
each patient, the proportion of depression-free days
(pDFDs) were calculated as the total number of depression-
free days, divided by the number of days the patient
participated in the study. Health service costs were calcu-
lated per patient for the participation period.
Both unadjusted and adjusted multiple regression ana-
lyses were undertaken to determine differences between
models of care in the pDFDs experienced and health ser-
vice costs. To adjust for potential confounders, propen-
sity score weighted analyses were used [27]. Variables
considered as potential covariates in the logistic regres-
sion model included: patient age, gender, marital status,
socioeconomic status (based on postcode level census
data (SEIFA score)), concessional status, relevant phys-
ical comorbidites (myocardial infarction, ischemic heart
disease, congestive heart failure, stroke, cancer, diabetes,
respiratory disease, musculoskeletal conditions and chronic
pain), relevant psychological comorbidities (alcohol or
drug abuse, gambling addiction, postnatal depression,
anxiety disorder, post traumatic stress disorder, obsessive
compulsive disorder, eating disorders, and social or
other phobia), measures of practice loyalty (the length
of time since the patient first attended the practice, the
proportion of visits to a GP during the study that were
at the participating practice, and the number of prac-
tices attended during the study), depression history (the
length of time since the first recorded depressive epi-
sode (which may or may not have been prior to the
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the study period) and the number of days the patient
participated in the study.
The distribution of pDFD contained distinct peaks at
both 0 and 1, and so a propensity weighted zero one in-
flated beta (ZOIB) model, with clustering of patients by
practice, was used for the adjusted analysis [28,29]. This
model contains three components: two separate logistic
regression models to predict whether the proportion is
equal to 0 or 1, and a beta model to predict proportions
between 0 and 1. Variables considered as potential co-
variates included those listed above, as well as GP char-
acteristics (age, gender, experience, and the number of
training sessions in depression undertaken in the previ-
ous two years), practice characteristics (bulk billing be-
haviour, practice size as measured by the number of
GPs, and the number of depression patients attending
the practice (defined as the number of eligible depres-
sion patients identified during the patient recruitment
CAT search)) and the model of care. Model fit was de-
termined using the Ramsey RESET test.
Adjusted analyses of health service costs were under-
taken, by fitting generalised linear models (GLMs),
which allowed for weighting using average treatment ef-
fect (ATE) weights [27] and clustering by general prac-
tice. The same variables, as listed for the ZOIB model,
were considered as potential covariates. Goodness of fit
was determined using the modified Park test (for the
GLM family) and the Pearson correlation test, the Pregi-
bon link test, and the modified Hosmer and Lemeshow
test (for the GLM link) [30]. Total costs were analysed
including and excluding hospital costs, to determine
whether hospital costs were an important driver of ex-
penditure. A bootstrapping approach (one thousand
bootstrap samples) was applied to represent the uncer-
tainty around the mean outcome and cost estimates.
Results
Ten general practices with practice nurses were re-
cruited to the PCSIP. One practice was later excluded as
only one patient with depression could be recruited from
this practice. On the basis of the practice nurse survey,
six practices were allocated to the low level model of
care and three to the high level model. Across the nine
practices, 208 depression patients were initially re-
cruited. The response rates were 33% (124 patients) and
30% (84 patients) for the low and high level models of
care, respectively.
Depression state classification
During data extraction and the subsequent classification
process, 54 of the 208 recruited patients (25 from the
high level model, 29 from the low level model) were ex-
cluded from the study. Exclusions occurred as it becameapparent from the extracted data that these patients did
not meet the defined inclusion criteria (e.g. they were
not depression patients but instead had a primary diag-
nosis of anxiety or had experienced symptoms indicative
of psychosis, received regular psychiatric care, were liv-
ing in managed accommodation, the participating prac-
tice was not the patients’ main practice, or the first
categorised visit was beyond the study period).
The level of detail provided in medical notes regarding
the patients’ experience of depression symptoms and
their severity varied between practices and GPs. Chronic
depression was particularly difficult to identify, while de-
pressive episodes, having higher symptom intensity and
greater functional impairment, appeared to be better
documented. In instances where medical notes were less
detailed, some states had to be inferred. An assumption
was made that symptoms were not present if not re-
corded, however the reality may be that symptoms
remained at lower levels. Where patients stated they had
experienced ‘long standing depression’, details of the de-
pression history were generally not provided, and we
were unable to determine if the patient experienced
episodes of depression interspersed with periods of well-
ness, or prolonged periods of depression with unremit-
ting symptoms (i.e. chronic depression).
Where present, distressing life events (both current
and historical) and comorbid conditions (such as anx-
iety, alcoholism, chronic pain or musculoskeletal injury)
often appeared to interact with, exacerbate or share
symptoms with depression. Thus it was challenging to
differentiate the course of a comorbidity from the course
of a depressive episode, particularly if, after initially not-
ing concurrent depression, the medical notes focussed
predominantly on the comorbidity.
While changes to antidepressant prescriptions pro-
vided a strong indicator of the course of a depressive
episode, limitations applied. Despite being offered, some
patients experiencing a depressive episode were unwill-
ing to take antidepressant medications. Some antidepres-
sants and mood stabilising medications were prescribed
for non-depression-related reasons, for example amitrip-
tyline for management of neuropathic pain or sodium
valproate for epilepsy. Patient compliance varied, with
some patients ceasing, decreasing or increasing dosages
independent of medical advice. Medications could be
ceased or dosages reduced due to side-effects or afford-
ability, rather than symptom abatement, and reasons for
changes were not always provided. These findings sug-
gest that antidepressant prescriptions have limited use as
a sole indicator of depressive state.
While most patients followed pathways congruent
with the proposed depression model structure (Figure 1),
three did not. One patient experienced a rapid onset of
depression and anxiety symptoms due to life events,
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state to a hospital admission. Two patients transitioned
from a hospital admission to a depressive episode, rather
than the response state as proposed. No patients died
during the study period.
Practice, GP and practice nurse characteristics
Characteristics of practices and practice nurses are
shown in Table 1. While no practice nurses reported
specific qualifications in the field of mental health care,
practice nurses in high level model practices attended
significantly more training sessions for depression in the
previous two years (1.33 sessions), compared with prac-
tice nurses in low level model practices (0.38 sessions,
p = 0.04). No other significant differences in practice or
practice nurse characteristics were found.
Patient characteristics
Patient characteristics for the 99 patients from low level
model practices and 55 patients from high level model
practices participating in the PCSIP are shown in Table 2.
In the unweighted (before adjustment) analysis, signifi-
cant differences (p < 0.05) existed between the models inTable 1 Practice, GP and practice nurse characteristics by mo
Practice characteristics (mean)
Number of practices in model
Number of GPs
Total number of patients with depression
GP age (years)
GP experience (years)
GP gender (proportion male)
Number of depression-related training sessions attended by GPs in last 2 yea
Practices bulk bill1 (proportion):
all patients
concession/pension card patients only
Billing of Medicare mental health item numbers (items per patient year)2
Practice nurse (PN) characteristics (mean per practice)
Number of PNs in model
Number FTE3 PNs per GP
PN age (years)
Experience working as a PN (years)
Experience working as a PN in the participating practice (years)
Number of depression-related training sessions attended by PNs in last 2 yea
Billing of Medicare item number 10997 (items per patient year)4
1The Medicare benefit paid for the visit is accepted as the full fee, therefore there i
numbers cover preparation of a GP mental health care plan by a medical practition
full time equivalent. 4Item number 10997 covers ‘provision of monitoring and supp
Aboriginal Health Worker on behalf of a GP’.terms of the socioeconomic status of the patient, the
duration of attendance at the participating practice, and
duration of study follow-up.
The application of propensity weights reduced differ-
ences between the two models for all but two patient char-
acteristics (gender, and whether the patient was in a
depressive state at the start of the study) and attained stan-
dardised differences of less than 0.1, indicating negligible
differences [31], for five of the twelve characteristics. The
subsequent use of propensity weighted regression further
controls for those variables with standardised differences
greater than 0.1.
Outcomes and costs
Unadjusted analyses found no significant differences in the
pDFDs between the high and low level models of care
(Table 3). Medicare out-of-hospital costs were significantly
higher for the high level model compared to the low level
model (high level = $2039, low level = $1502, p = 0.005), as
were total depression-related costs (high level = $2374, low
level = $1750, p = 0.01).
Adjusted analyses found no significant difference in
pDFDs or costs between the models of care (Table 3).del of care
















rs 0.38 1.33 0.04
0.08 0.06 0.64
s no out of pocket expense for the patient. 2Included mental health item
er (2702, 2710), and review of a GP Mental Health Treatment plan (2712). 3FTE:
ort to people with a chronic disease by a practice nurse or registered
Table 2 Patient characteristics, before and after propensity score weighting













Age (years) 52.56 51.14 0.12 (0.49) 50.13 51.00 −0.07 (0.70)
Gender (male) 0.24 0.28 −0.11 (0.53) 0.19 0.25 −0.14 (0.37)
Married or defacto relationship 0.49 0.38 0.22 (0.20) 0.40 0.40 −0.001 (0.996)
Concessional patient 0.80 0.68 0.28 (0.10) 0.66 0.70 −0.10 (0.68)
SEIFA score4 854.24 905.08 −0.70 (0.00) 877.86 887.05 −0.13 (0.60)
Time since first recorded depressive episode (days) 824.91 1226.00 −0.32 (0.06) 1068.46 1135.63 −0.05 (0.78)
In a depressive state at start of study5 0.60 0.52 0.17 (0.31) 0.66 0.56 0.20 (0.26)
Pre-study chronic condition6 0.58 0.52 0.13 (0.43) 0.51 0.51 −0.01 (0.96)
Pre-study psychological condtion7 0.15 0.18 −0.10 (0.57) 0.16 0.17 −0.03 (0.89)
Time attending the practice (days) 816.58 1564.69 −0.65 (0.00) 1118.51 1280.96 −0.14 (0.52)
Percentage of GP visits in the study period to the participating
practice
0.94 0.93 0.15 (0.39) 0.94 0.93 0.11 (0.50)
Time in study (days) 799.02 882.05 −0.38 (0.02) 812.96 843.78 −0.14 (0.54)
1Adjustment is based on propensity score weighted analysis. 2Low level model includes 99 patients, high level model includes 55 patients. 3Standardised
difference is the difference between the means for the low and high level practices divided by the standard deviation (p value is for differences). 4SEIFA is the
Socio-Economic Index for Areas (lower scores indicate more disadvantage, Australia wide scores are standardised to a mean of 1000). 5Depressive states include
depressive episode, chronic depression, hospital admission for depression, or response. 6Pre-study chronic conditions include myocardial infarction, ischemic heart
disease, congestive heart failure, stroke, cancer (excluding skin cancer), diabetes, respiratory disease (e.g. asthma, COPD), musculoskeletal conditions (e.g. arthritis)
and chronic pain. 7Pre-study psychological conditions include alcohol or drug abuse, gambling addiction, postnatal depression, anxiety disorder, post traumatic
stress disorder, obsessive compulsive disorder, eating disorders, and social or other phobia.
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measure (total depression-related costs) and outcome vari-
able (proportion of depression-free days), the high-level
practice nurse model of care was shown to cost more and
resulted in 5% less depression-free days than the low level
model. However, this result is highly uncertain. A boot-
strapped sensitivity analysis generated a 95% confidence
interval that ranged from 15% less to 5% more depression-
free days for the high level model of care, with a cost











Medicare out-of-hospital costs $1502 $2039








Total costs $4652 $4954 $
Total depression-related costs4 $1750 $2374
1Adjustment is based on propensity score weighted analysis. 2For all pharmaceutica
medications supplied under the PBS. 4Total depression-related costs = Medicare out
depression-related hospital costs.A cost-effectiveness plane, showing five thousand boot-
strapped samples, was generated to demonstrate the un-
certainty (Figure 2). While the sampled values spread
across all four segments of the plane, 62% are positioned
in the north west quadrant, in which the high level model
is more costly and less effective than the low level model.
Discussion
This study has reported on the application of a frame-
work to classify depression-related states of health usingernative models of care
ent After adjustment1




High level minus low level model
mean difference (95% CI)
p
value
0.04 (−0.17 to 0.09) 0.54 −0.05 (−0.15 to 0.05) 0.31
$537 (165 to 909) 0.005 $33 (−270 to 337) 0.83
$204 (−340 to 749) 0.46 $147 (−161 to 456) 0.35
$14 (−50 to 79) 0.65 $41 (−7 to 89) 0.09
$439 (−1513 to 636) 0.42 $181 (−742 to 1103) 0.70
$72 (−206 to 351) 0.61 — —
302 (−1155 to 1760) 0.68 $574 (−487 to 1635) 0.29
$624 (150 to 1098) 0.01 $135 (−315 to 584) 0.56
ls supplied under the Pharmaceutical Benefits Scheme (PBS). 3Antidepressant




































   
)
Incremental  effect 
(proportion of depression free days)
Figure 2 Cost-effectiveness plane. Incremental (high level minus low level model) costs and effects after adjustment. Black square shows
mean values.
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The resulting classifications informed a cost-effectiveness
analysis of alternative levels of involvement of prac-
tice nurses in the care of patients with depression in an
Australian primary health care setting.
The process of manually categorising depressive state
was time consuming, but feasible using the protocol de-
scribed. Almost all observed transitions between states
followed pathways consistent with the proposed depres-
sion model, suggesting strong congruence between the
proposed model structure and the observed data.
Variation in the level of detail provided in general
practice medical notes may have been a source of poten-
tial bias, especially as it was necessary to assume that
the absence of notes regarding depressive symptoms in-
dicated the absence of symptoms. This is of particular
concern for chronic depression, where persistent low to
moderate level symptoms may be less likely to be re-
corded, especially by GPs who are providing a lower in-
tensity of depression care.
In future applications, the inclusion of a measure of
uncertainty for each classified state may be one way of
quantifying bias in the classification process. For ex-
ample, adding a notation on whether a state was allo-
cated based on multiple indicators, a single indicator or
via time-based assumptions only.
The classification framework expands on methods
used in previous studies, which have classified depressive
state based solely on the antidepressant prescription in-
formation available in routinely collected medical re-
cords [21,22]. For example, Sicras-Mainer et al. [22]
defined patients as entering remission after completing
six months of antidepressant therapy. Discontinuation of
the antidepressant was not considered evidence of re-
mission as patients may discontinue for other reasons,
or continue treatment for prolonged periods despitebeing asymptomatic. Comparing remission identified via
antidepressant use and remission identified through a
review of a random sample of patient medical records,
Sicras-Mainer et al. found high concordance between
the two measures. Details of how remission was deter-
mined in the medical record review were not supplied.
Nordstrom et al. [21] determined depressive relapse on
the basis of an antidepressant prescription received
within one to six months of ceasing an antidepressant.
The PCSIP found that, while changes to antidepressant
prescriptions provided an indication of depressive state,
there were limitations to using them as a sole means of
classification. For example, cross-referencing Medicare
and general practice data found that not all prescriptions
written were supplied under the PBS. Patient medical
notes also indicated that not all antidepressant prescrip-
tions were written to treat depressive symptoms. This is
consistent with the findings of the Bettering the Evalu-
ation and Care of Health (BEACH) programme [32],
which continually surveys general practice activity across
Australia. The BEACH programme found only 70% of
antidepressant prescriptions were for depression. The
remaining 30% were prescribed for other psychological
issues, such as anxiety, phobias, or eating disorders, or
for non-psychological issues, such as musculoskeletal
and neurological problems.
Further work is required to validate the developed
classification framework. This will require a comparison
of classifications based on routinely collected data
sources with classifications based on either diagnostic
interview of patients or responses to standardised de-
pression assessment tools taken independently of routine
practice at regular time intervals. Threshold values on
these tools are commonly used to define depression
states (such as response, remission, recurrence) in RCT
based modelling studies [33,34].
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level of practice nurse involvement, rather than assessing
only the presence or absence of a practice nurse; the al-
location of general practices to models of care based on
existing differences, rather than through the imposition
of an intervention, allowing the study to examine the
real world impact; and the classification of depression
state using the framework derived, rather than relying
on medication changes alone.
The study was subject to some limitations, including:
the relatively small sample size, particularly given the
high level model did not reach the numbers indicated by
the sample size calculation; the allocation of practices to
models of care based on the subjective responses of
practice nurses; and the observational study design
which, despite the rigorous methods used to minimise
bias due to observed confounders (i.e. combined use of
propensity score weighting and regression analyses), still
had an associated likelihood of unobserved confounding
between the two models of care (for example, unknown
differences in the number of previous depressive epi-
sodes, or occurrence of stressful life events). Unobserved
differences in the characteristics of patients consenting
and not consenting to participate in the study may have
resulted in a selection bias, which would reduce the rep-
resentativeness of the sample population to the general
depression population. Cost values were not discounted
over the three year time horizon and Medicare costs
remained in the unit cost of the year incurred, rather
than being re-estimated for a single base year. Given the
relatively short time horizon of the study, the con-
sistency in cost allocation methods across the models of
care and the small difference in costs found, this is un-
likely to have had a significant effect on the findings of
the study.
In interpreting the finding of no significant difference
in costs and outcomes between the models of care it is
pertinent to consider that, although practice nurses in
the high level model attended more depression related
training sessions, none of the practice nurses in the
study had formal qualifications in mental health care or
experience working in a mental health nurse role. Infor-
mation was not collected on the duration of training ses-
sions attended, however, at the time of the study, the
majority of training sessions for practice nurses were
provided by the ANDGP. These consisted of evening
education sessions lasting approximately two and a half
hours (ANDGP, personal communication, 17 May 2011).
Therefore, the actual difference in the number of hours
of training may equate to as little as two and a half
hours over the two years. Thus, the result may reflect
similar, low levels of mental health training across both
models of care. Although the study did not include a ‘no
practice nurse’ model of care, the findings imply thatpractice nurses with low levels of training in mental
health have a limited effect on the outcomes of patients
with depression.
Existing evidence indicates that the inclusion of case
managers, who are often nurses, in collaborative care for
depression is effective [5-7] and cost-effective [8]. How-
ever, it is vitally important that nurses engaged in this
role receive adequate training and ongoing support [5,7].
Effectiveness is further improved if the nurse is able to
provide psychological therapies as a part of enhanced
care [6]. For example, the IMPACT method includes 4
days of training, 30 sessions with ‘training patients’ and
15 supervised sessions with videotape review. The nurse
is then able to provide patient education, discuss treat-
ment options, conduct follow-up and deliver a 6 to 8
session psychotherapy based intervention [35]. The
TrueBlue study, which translates the IMPACT method-
ology to the Australian setting, provides 2 days of train-
ing, though this covers chronic disease management for
diabetes and heart disease, as well as depression care
(screening and counselling). Practice nurses were also
given case management templates that provided written
protocols for “gold-standard” depression management,
as well as ongoing expert and peer support [14-16].
Since 2007, the Mental Health Nurse Incentive Program
(MHNIP) has provided incentives for Australian general
practices, private psychiatry practices and Indigenous
health services to employ a credentialed mental health
nurse [36]. In 2012, there were 1,153 credentialed men-
tal health nurses in Australia and the MHNIP had been
taken up by 470 organisations [37]. Unfortunately, none
were employed in the ANDGP area at the time of the
PCSIP to enable comparison with generalist practice
nurses.
Despite the limitations, and in line with previous stud-
ies, the PCSIP findings suggest that practice nurses in-
volved in the management of patients with depression
require specific training in mental health. They suggest
that without focused training and support, it is not an
efficient use of scarce nursing time to promote greater
involvement of generalist nurses in the care of depressed
patients. Training may range from two days (the True-
Blue study) to a university awarded postgraduate qualifi-
cation with additional work experience (mental health
nurse credential required to receive the MHNIP). Other
RAC-E studies have shown that greater practice nurse
involvement in the care of patients with diabetes and
obesity is cost-effective [19,20]. Thus, in primary care
settings where no specific framework for mental health
training and support has been provided, practice nurse
time might be better targeted towards diabetic or obese
patient groups.
The general methods used in the PCSIP, including the
application of the RAC-E methodology and the depression
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of evaluating real world interventions in the primary care
setting. The non-significant differences found in out-
comes and costs illustrate the value of such evaluations,
particularly for those involved in policy and planning de-
cisions, such as expansion or redirection of financial
incentives.
Conclusions
This study has shown that it is feasible to classify de-
pression status based on routinely collected clinical data
collated from multiple sources. Further research is re-
quired to validate the described classification process,
and findings should be interpreted with some caution
until this has been done.
This paper used data from a retrospective observational
study based on routinely collected data. It has reported
small and non-significant differences in health service costs
and proportions of depression-free days between patients
attending general practices in which practice nurses were
defined as having a high level of involvement in the clinical
care of depression patients, and practices with a low level
of practice nurse involvement. Further research might focus
on the costs and effects of different levels of training and
support for practice nurses in a mental health role and the
use of specialist mental health nurses in routine general
practice.
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